Tablet and Ampoule Therapy (Medicines that are not Tender - 139539129

The PHI UNIVERSITY CLINIC FOR NEUROSURGERY has issued a Tender notice for the procurement of a Tablet and Ampoule Therapy (Medicines that are not on the Positive List) in the Macedonia. This Tender notice was published on 15 Apr 2026 and is scheduled to close on 14 May 2026, with an estimated Tender value of Refer Document. Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 139539129, while the tender notice number is 06369/2026 and Registering on the platform.

Expired Tender

Procurement Summary

Country: Macedonia

Summary: Tablet and Ampoule Therapy (Medicines that are not on the Positive List)

Deadline: 14 May 2026

Posting Date: 15 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 139539129

Document Ref. No.: 06369/2026

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

33673000 - Medicinal products for obstructive airway diseases
33670000 - Medicinal products for the respiratory system
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33630000 - Medicinal products for dermatology and the musculo-skeletal system
33693000 - Other therapeutic products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

PART 1 B01AC06 Acetylsalicylic acid, PART 2 C01EB10 Adenosine, PART 3 N04BB01 Amantadine, PART 4 ​​N04BB01 Amantadine, PART 5 A12AA03 B05BB01 Calcium gluconate, PART 6 N06BX Cerebrolysin concentrat, PART 7 B02BD01 Coagulation factor IX, II, VII and X in combination, PART 8 M03CA01 Dantrolene, PART 9 N05CM18 Dexmedetomidine, PART 10 N05CM18 Dexmedetomidine, PART 11 C01CA26 Ephedrine, PART 12 C07AB09 Esmolol, PART 13 A02BA03 Famotidine, PART 14 M01AE01 Ibuprofen, PART 15 A07FA51 Lactic acid producing organisms, combinations, PART 16 N01BB02 Lidocaine, PART 17 N01BB02 Lidocaine, PART 18 J01X08 Linezolid, PART 19 B05XA05 Magnesium sulfate, PART 20 N02BB02 Metamizole sodium, PART 21 C08CA06 Nimodipine, PART 22 C01CA06 Phenylephrine, PART 23 C01CA06 Phenylephrine, PART 24 N05AA03 Promazine, PART 24 25 V03AB35 Sugammadex, Д 26 N05AL01 Sulpiride, Д 27 B02AA02 Tranexamic acid, Д 28 H01BA01 Vasopressin (argipressin), Д 29 R03BB01 Ipratropium bromide, Д 30 B02BB01 human fibrinogen, ДЕЛ 31 J01DI02 ceftaroline fosamil, ДЕЛ 32 J01DD52 ceftazidime avibactam, ДЕЛ 33 A01AB12 Hexetidine, DEL 34 N02BE51 paracetamol, ibuprofen D, EL 35 J01AA12 Tygex, DEL 36 S01BC08 Salicylic acid,
CPV Descriptions: Medical products for the treatment of diseases causing airway obstruction, Medical products for the respiratory system, General anti-infectives for systemic use, vaccines, antineoplastic agents and immunomodulating agents, Medical products for dermatology and the musculoskeletal system, Other therapeutic products

Documents

 Tender Notice

Document_1.xlsx

Document_2.docx

Document_3.doc

Document_4.pdf


Similar Tenders

Request Demo
GiZ Tenders India

Procurement Documents for Macedonia

Access a comprehensive library of standard procurement documents specific to Macedonia. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Macedonia

Explore Procurement Documents for Macedonia


Want To Bid in This Tender?

Get Local Agent Support in Macedonia and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?